ArticleBMC endocrine disorders2014

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy.

Judith L White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.